Manual and description of the drug
Sovihep (Generic Sovaldi)
Sovihep (sofosbuvir) is an inhibitor of NS5B polymerase of hepatitis C virus (HCV) and
it is used to treat chronic hepatitis C as a component of combination schemes of antiviral therapy in adult patients in combination with other drugs. You can buy sovihep from india at good price, We Medimpex India exports Hepcinat 4000mg tablet to Russia, Kazakhstan, Kyrgyzstan, latvia, Poland, Belarus, Romania, Peru, Mexico, China, United states, United Kingdom, South Korea and many more countries.
Sovihep is an antiviral agent direct action, inhibiting RNA-dependent
polymerase NS5B of hepatitis C virus required for replication of the virus.
Sovihep comes in the shape of oval coated tablets, which dissolve only in the environment of the stomach. Each tablet contains 400 mg sofosbuvir.
Visible therapeutic effect is observed due to the activity of the active substance called Sofosbuvir, which has systemic effects in the affected With hepatitis C the body.
Sovihep 1 tablet contains: sofosbuvir 400 mg.
INDICATIONS FOR USE:
Sovihep is indicated for use in combination with other medicines to treat
chronic hepatitis C in adult patients.
Efficacy established in patients infected with hepatitis C virus genotype 1, 2, 3 or 4, including patients with hepatocellular carcinoma that meets the Milan criteria (awaiting liver transplantation) and patients with co-infection of HIV-1.
METHOD OF APPLICATION AND DOSE:
In the appointment of treatment with sofosbuvir, consider the following information.
- Monotherapy with sofosbuvir is not recommended for the treatment of chronic hepatitis C.
- The scheme and duration of treatment depend on both viral genotype and accessories
patient to a specific population*.
- Response to treatment is determined by the original factors of the virus and the host.
The recommended dose of sofosbuvir is one tablet of 400 mg orally 1 time daily with or without food.
Sofosbuvir administered in combination with ribavirin or with pegylated interferon alpha and ribavirin. Contraindications to the use of these drugs is valid for combination therapy. Contraindications to peginterferon Alfa and ribavirin is provided in the respective instructions for use of these drugs.
Combination therapy with sofosbuvir with ribavirin or peginterferon Alfa is contraindicated in pregnant women or women who may become pregnant and men whose female partners are pregnant, because of the risk of birth defects and fetal death associated with ribavirin action.
At a temperature of from 15 to 30 °C.